• COVID-19 demand leads to Australian shortages of rheumatoid arthritis drug

    1 month ago - By Sydney Morning Herald

    The medicines regulator and pharma giant Roche are monitoring the availability of arthritis treatment Actemra, which has had supply constrained by overseas use for COVID-19.
    Read more ...